Scarica l'app Stockscreener
3.92
2.00%
-0.08
Dopo l'orario di chiusura:
3.93
0.01
+0.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VTYX Giù?
Forum
Previsione
Precedente Chiudi:
$4.00
Aprire:
$3.93
Volume 24 ore:
983.12K
Relative Volume:
1.02
Capitalizzazione di mercato:
$279.53M
Reddito:
-
Utile/perdita netta:
$-192.96M
Rapporto P/E:
-1.1879
EPS:
-3.3
Flusso di cassa netto:
$-167.04M
1 W Prestazione:
+10.11%
1M Prestazione:
+69.70%
6M Prestazione:
+266.36%
1 anno Prestazione:
+60.00%
Intervallo 1D:
$3.822
$3.98
Intervallo di 1 settimana:
$3.50
$4.115
Portata 52W:
$0.783
$4.115
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Nome
Ventyx Biosciences Inc
Settore
Industria
Telefono
(858) 945-2393
Indirizzo
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Confronta VTYX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
3.92 | 285.23M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-12 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-03-12 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2023-11-07 | Downgrade | Stifel | Buy → Hold |
| 2023-11-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | Ripresa | Credit Suisse | Outperform |
| 2023-03-21 | Iniziato | Wells Fargo | Overweight |
| 2022-12-19 | Iniziato | Goldman | Buy |
| 2022-11-17 | Iniziato | Morgan Stanley | Overweight |
| 2022-09-07 | Iniziato | Stifel | Buy |
| 2022-09-01 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-09 | Iniziato | Credit Suisse | Outperform |
| 2022-03-31 | Iniziato | Canaccord Genuity | Buy |
| 2022-02-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-15 | Iniziato | Jefferies | Buy |
| 2021-11-15 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Ventyx Biosciences Inc Borsa (VTYX) Ultime notizie
Is Ventyx Biosciences Inc. stock supported by strong cash flowsWeekly Profit Summary & Long-Term Capital Growth Ideas - Trung tâm Dự báo KTTV quốc gia
Is Ventyx Biosciences Inc. stock a safe buy before earningsEarnings Trend Report & Reliable Price Breakout Signals - Trung tâm Dự báo KTTV quốc gia
Real time breakdown of Ventyx Biosciences Inc. stock performance2025 Big Picture & Technical Buy Zone Confirmation - newser.com
Technical signs of recovery in Ventyx Biosciences Inc.Risk Management & Advanced Technical Signal Analysis - newser.com
Will Ventyx Biosciences Inc. see short term momentumWeekly Risk Report & AI Forecast Swing Trade Picks - newser.com
Will Ventyx Biosciences Inc. stock split again soonAnalyst Upgrade & Risk Adjusted Buy/Sell Alerts - newser.com
Multi factor analysis applied to Ventyx Biosciences Inc.Earnings Overview Summary & AI Powered Market Trend Analysis - newser.com
Will Ventyx Biosciences Inc. stock benefit from infrastructure spendingMarket Performance Report & Capital Protection Trading Alerts - newser.com
Is Ventyx Biosciences Inc. stock supported by innovation pipeline2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Chart based exit strategy for Ventyx Biosciences Inc.July 2025 Action & Expert Curated Trade Setups - newser.com
Detecting price anomalies in Ventyx Biosciences Inc. with AI2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
Analyzing drawdowns of Ventyx Biosciences Inc. with statistical toolsMarket Risk Summary & Capital Protection Trade Alerts - newser.com
Live market analysis of Ventyx Biosciences Inc.2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Relative strength of Ventyx Biosciences Inc. in sector analysisQuarterly Trade Report & Risk Adjusted Buy/Sell Alerts - newser.com
How high can Ventyx Biosciences Inc. stock go2025 Market Trends & High Accuracy Swing Entry Alerts - newser.com
Is this a good reentry point in Ventyx Biosciences Inc.Market Risk Analysis & Trade Opportunity Analysis Reports - newser.com
Ventyx Biosciences' (VTYX) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Ventyx Biosciences, Inc. (VTYX) Is Up 20.81% in One Week: What You Should Know - sharewise.com
Sentiment analysis tools applied to Ventyx Biosciences Inc.Earnings Trend Report & Long-Term Growth Portfolio Plans - newser.com
Is Ventyx Biosciences Inc. stock a top pick in earnings seasonTrade Exit Summary & Real-Time Market Sentiment Reports - newser.com
Is Ventyx Biosciences Inc. stock in correction or buying zoneJuly 2025 Final Week & Proven Capital Preservation Tips - newser.com
What’s the recovery path for long term holders of Ventyx Biosciences Inc.Market Growth Summary & Weekly Setup with High ROI Potential - newser.com
Signal strength of Ventyx Biosciences Inc. stock in tech scanners2025 Investor Takeaways & Expert Approved Trade Ideas - newser.com
Analyzing recovery setups for Ventyx Biosciences Inc. investorsJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Ventyx Biosciences Inc Azioni (VTYX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):